Item 5.07 Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 28, 2022. (b) Shareholders voted on the matters set forth below.



1. The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.S. Securities and
Exchange Commission on March 17, 2022 were elected to hold office until the Company's next Annual Meeting of Shareholders, based upon the following
votes:
Nominee                                              Votes For             Votes Against                 Abstentions            Broker non-vote
Ronald E. Blaylock                               3,701,357,646                97,026,302                  10,925,480                849,628,501
Albert Bourla                                    3,577,655,169               204,869,446                  26,783,357                849,628,501
Susan Desmond-Hellmann                           3,744,546,772                54,872,805                   9,887,325                849,628,501
Joseph J. Echevarria                             3,315,350,611               483,108,900                  10,848,394                849,628,501
Scott Gottlieb                                   3,775,202,986                23,651,661                  10,414,283                849,628,501
Helen H. Hobbs                                   3,704,020,993                95,742,430                   9,505,507                849,628,501
Susan Hockfield                                  3,773,537,829                25,701,939                  10,029,162                849,628,501
Dan R. Littman                                   3,741,506,546                57,146,873                  10,615,511                849,628,501
Shantanu Narayen                                 3,766,994,058                31,021,763                  11,292,326                849,628,501
Suzanne Nora Johnson                             3,605,854,757               193,599,113                   9,854,277                849,628,501
James Quincey                                    3,729,849,039                68,041,486                  11,406,359                849,628,501
James C. Smith                                   3,694,497,573               103,133,820                  11,676,754                849,628,501





2. The proposal to ratify the selection of KPMG LLP as the Company's independent registered public
accounting firm for the 2022 fiscal year was approved based upon the following votes:

Votes for approval                           4,440,636,499
Votes against                                  204,291,133
Abstentions                                     14,009,991
Broker non-votes                                       n/a

3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:



Votes for approval                           3,509,011,827
Votes against                                  275,230,428
Abstentions                                     25,057,788
Broker non-votes                               849,628,501


--------------------------------------------------------------------------------



4. The shareholder proposal regarding amending proxy access was not approved based upon the following
votes:

Votes for approval                         1,096,172,490
Votes against                              2,686,465,588
Abstentions                                   26,655,147
Broker non-votes                             849,628,501

5. The shareholder proposal regarding report on political expenditures congruency was not approved
based upon the following votes:
Votes for approval                           393,729,907
Votes against                              3,387,577,521
Abstentions                                   27,996,591
Broker non-votes                             849,628,501


6. The shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers was not approved based upon the following votes:



Votes for approval                         1,023,141,083
Votes against                              2,714,524,824
Abstentions                                   71,640,637
Broker non-votes                             849,628,501

7. The shareholder proposal regarding report on board oversight of risks related to anticompetitive practices was not approved based upon the following votes:



Votes for approval                         1,138,551,810
Votes against                              2,600,688,619
Abstentions                                   70,069,294
Broker non-votes                             849,628,501

8. The shareholder proposal regarding report on public health costs of protecting vaccine technology was
not approved based upon the following votes:
Votes for approval                           325,762,383
Votes against                              3,415,442,745
Abstentions                                   68,096,240
Broker non-votes                             849,628,501







--------------------------------------------------------------------------------

© Edgar Online, source Glimpses